Stocktoria

Qiagen N.V. QIA.DE

DE · Deutsche Börse Xetra · XETR · stock · Healthcare · website

Qiagen N.V. statistics & valuation

P / E16.5×
P / S3.3×
P / B1.9×
P / FCF15.6×
Net margin20.3%
FCF margin21.4%

Multiples are price-derived and refreshed daily; everything else is from filings.

P / E vs its own history

Qiagen N.V. trades at about 16.6× earnings — below its 10-year norm (10-year range 17.9×–112.7×, median 26.5×).

16.6× 112.7×

Shaded band = 10-year range (17.9×–112.7×); dot = today's 16.6×.

Historical P/E = month-end price near each fiscal year-end ÷ that year's EPS. A read on whether the stock is cheap or dear relative to how it has typically been valued — not a forecast.

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022
Gross margin62.2%48.9%62.8%64.7%
Operating margin24.9%10.1%22.7%26.9%
Net margin20.3%4.2%17.4%19.8%
FCF margin21.4%25.4%15.1%26.4%
Return on assets6.8%1.5%5.6%6.7%
Return on equity11.2%2.3%9.0%12.2%
Debt / equity0.44×0.24×0.24×0.42×
Current ratio3.901.881.992.46

Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.